Tests remote vital signs monitoring for people using long-term oxygen
Tests remote monitoring of vital signs in adults using long-term oxygen for lung disease.
Plain-language title generated from the registry record
Registry title: Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy
Key facts
- Where
- São Paulo, BrazilSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT06882265, who can take part
Where in Brazil
- Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo HcfmuspSão Paulo, BrazilTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Sao Paulo General Hospital
- Trial code
- NCT06882265
- Record updated
- 18 March 2025
- Original description
Assess quality of life of patients using prolonged oxygen therapyRead full original descriptionShow less
Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy : a Randomized Clinical Trial
Assess quality of life of patients using prolonged oxygen therapy
Inclusion: Patients with a clinical, radiological and/or anatomopathological diagnosis of COPD and ILD according to the 2020 ATS/JRS/ALAT guidelines; Age over 18 years; Clinical stability (absence of exacerbations or hospitalizations related to the underlying disease) for at least 6 weeks; Patients who are on optimized drug therapy, including long-term home oxygen therapy (LTOT); Have a smartphone compatible with the monitoring device; Signing of the ICF to participate in the study.
Exclusion: Presence of other concomitant lung diseases; Myocardial infarction within four months prior to the start of the study, unstable angina or severe heart disease (NYHA functional class III-IV) and/or decompensated; Patients who received a lung transplant during the study; Living outside the coverage area or moving out of state.